Breast Cancer Update for Surgeons, Issue 1, 2017 (Video Program)


SLNB after neoadjuvant chemotherapy in patients with node-negative versus node-positive BC
2:19 minutes.

Use of genomic assays to assist in clinical decision-making for patients with ER-positive early breast cancer (BC)

Tailoring treatment for patients with ductal carcinoma in situ (DCIS)

Timing and role of sentinel lymph node biopsy (SLNB)

Other issues in the treatment of early BC: Maintaining fertility and use of adjuvant bisphosphonates

Treatment of HER2-positive and triple-negative BC